TuHURA Biosciences (HURA) EBT (2010 - 2012)

TuHURA Biosciences' (HURA) quarterly EBT came in at -$7405.0 in Q4 2012, up 62.24% year-on-year from -$4564.2 in Q1 2012, and down 78.22% quarter-over-quarter from -$4155.0 in Q3 2012.

TuHURA Biosciences (HURA) EBT (2010 - 2012) Analysis & Trends

TuHURA Biosciences' EBT history runs 3 years deep, the most recent figure standing at -$7405.0 for Q4 2012.

  • On a quarterly basis, EBT rose 62.24% year-over-year to -$7405.0 in Q4 2012; TTM through Dec 2012 was -$39808.0, a 11.28% increase from a year earlier, with the FY2012 full-year figure at -$18885.0, up 43.01% from the prior year.
  • EBT eased to -$7405.0 in Q4 2012 per HURA's latest filing, from -$4155.0 in the prior quarter.
  • Across five years, EBT topped out at -$3858.0 in Q3 2011 and bottomed at -$23526.0 in Q1 2012.
  • The 3-year median for EBT is -$7118.0 (2011), against an average of -$10584.6.
  • Across the five-year window, EBT sank 34.62% in 2011 and surged 62.24% in 2012, its largest moves.
  • Year by year, EBT stood at -$14568.0 in 2010, then sank by 34.62% to -$19612.0 in 2011, then jumped by 62.24% to -$7405.0 in 2012.
  • Per Business Quant, the three latest HURA EBT figures stand at -$7405.0 (Q4 2012), -$4155.0 (Q3 2012), and -$4722.0 (Q2 2012).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -36.97 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -15.31 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 259.22 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 831.20 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -26.94 Mn
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 541.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -453.82 Mn
10 TuHURA Biosciences 132.62 Mn 132.62 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2012 -7,405.00
Sep 30, 2012 -4,155.00
Jun 30, 2012 -4,722.00
Mar 31, 2012 -23,526.00
Dec 31, 2011 -19,612.00
Sep 30, 2011 -3,858.00
Jun 30, 2011 -6,831.00
Dec 31, 2010 -14,568.00